Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q2 2018 · 10-Q
Revenue$122.46M$122.46M+11.2% vs Q2 2017 Net Income$487.00K$487.00K−63.3% vs Q2 2017 EPS Diluted$0.02$0.02−60.0% vs Q2 2017 Gross Profit$14,921,000−12.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flow$6,336,000−34.8% Free Cash Flowderived-$824,000N/M Margins · derivedGross margin12.2%−3.3 pt vs Q2 2017
Operating margin-0.6%−3.5 pt vs Q2 2017
Net margin0.4%−0.8 pt vs Q2 2017
ended Nov 26, 2017 · filed Jan 5, 2018 · 40 d after period end